A biological age score predicts that being male, overweight, a smoker and having depression all contribute to biological aging, a study published today in
Date Time
Anticancer drug may improve outcome for severe COVID-19 patients
Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020. On average, blood oxygen levels, body temperature and inflammatory markers significantly improved in patients treated with a single dose of bevacizumab in addition to standard care. The research is published in Nature Communications.
Yihai Cao, photo: Ulf Sirborn
“To reduce COVID-19 mortality, we aim to develop an effective therapeutic paradigm for treating patients with severe COVID-19,” says corresponding author Yihai Cao, professor of vascular biology at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet. “Our findings suggest that bevacizumab plus standard care is highly beneficial for patients with severe
Volvos utdelning får Sverige att rulla barometern.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from barometern.se Daily Mail and Mail on Sunday newspapers.
E-Mail
A decision-support tool that could be accessed via mobile devices may help clinicians in lower-resource settings avoid unnecessary antibiotic prescriptions for children with diarrhoea, a study published today in
eLife shows.
The preliminary findings suggest that incorporating real-time environmental, epidemiologic, and clinical data into an easy-to-access, electronic tool could help clinicians appropriately treat children with diarrhoea even when testing is not available. This could help avoid the overuse of antibiotics, which contributes to the emergence of drug-resistant bacteria. Diarrhoea is a common condition among children in low-resource settings, explains lead author Benjamin Brintz, Research Associate at the Division of Epidemiology, University of Utah Health, Salt Lake City, US. Antibiotics are often prescribed for it, despite the fact these medications will not help patients who have diarrhoea caused by viruses. Helping clinicians determine if a case of di
E-Mail
IMAGE: Daniel Simon, associate professor in the Laboratory of Organic Electronics, Department of Science and Technology at Linköping University. view more
Credit: Thor Balkhed
Researchers at Linköping University, Sweden, have developed a proton trap that makes organic electronic ion pumps more precise when delivering drugs. The new technique may reduce drug side effects, and in the long term, ion pumps may help patients with symptoms of neurological diseases for which effective treatments are not available. The results have been published in
Science Advances.
Approximately 6% of the world s population suffer from neurological diseases such as epilepsy, Parkinson s disease, and chronic pain. However, currently available drug delivery methods - mainly tablets and injections - place the drug in locations where it is not required. This can lead to side effects that harm the patient.